Welcome to our dedicated page for Infosys news (Ticker: INFY), a resource for investors and traders seeking the latest updates and insights on Infosys stock.
Infosys Limited reports recurring developments in AI-first business consulting, technology services, digital transformation and enterprise modernization. Company news commonly covers Infosys Topaz, its generative and agentic AI offering, Infosys Topaz Fabric for agentic services, and Infosys Cobalt for cloud services, solutions and platforms.
Updates also include strategic collaborations with technology, education, sports and enterprise customers; work for financial-services clients; software engineering and legacy modernization initiatives; digital fan-engagement platforms; brand and partnership announcements; and operating or financial results. Infosys serves clients through a global IT services model that includes consulting, cloud, AI, infrastructure, software delivery and business process outsourcing.
Infosys (NYSE: INFY) has been recognized as a Leader in the Everest Group ServiceNow Services PEAK Matrix® Assessment 2021, highlighting its expertise in delivering comprehensive ServiceNow solutions. The report emphasizes Infosys' strong IP tools and accelerators, including the Enterprise Service Management Café, which accelerates implementation timelines by 40-50%. The company is noted for its high client satisfaction scores and extensive capabilities across various ServiceNow services, showcasing its commitment to transformative service management.
Infosys (NYSE: INFY) has acquired Blue Acorn iCi, a renowned customer experience and analytics company, for $125 million. This acquisition enhances Infosys's end-to-end offerings in commerce and analytics, building on Blue Acorn iCi's accolades, including being named Adobe Emerging Solution Partner of the Year. The integration aims to leverage Blue Acorn iCi's expertise to drive digital transformation for enterprises. This partnership is expected to boost Infosys's capabilities in handling direct-to-consumer services and strengthen its market position.
Infosys announced its ESG Vision 2030, emphasizing commitments to climate change, diversity, and community development. The company is now carbon neutral, following PAS 2060 standards, and significantly reduced per capita electricity consumption by over 55%. In FY2020, 44% of its electricity came from renewables. Current initiatives aim to empower over 10 million people digitally and maintain a workforce with at least 45% women employees. Infosys' substantial investments in community projects total over $55 million annually.
Infosys reported a 2.2% year-on-year revenue growth for Q2 2020, reaching $3,312 million. Digital offerings surged by 25.4%, constituting 47.3% of total revenue. Operating margins improved by 370 basis points to 25.4%. Q2 net profit rose 14.7% to $653 million, with free cash flow increasing 69.8%. The company declared an interim dividend of INR 12 per share, up 50% YoY. Increased guidance for FY 21 includes revenue growth revised to 2%-3% and operating margin to 23%-24%. Infosys secured notable client partnerships amidst challenging conditions.
Infosys (NYSE: INFY) has completed its acquisition of Kaleidoscope Innovation, enhancing its capabilities in smart product design across medical, consumer, and industrial markets. This acquisition, announced on September 3, 2020, aligns with Infosys' commitment to innovation and impacts patient care and diagnostics. Kaleidoscope's expertise includes microsurgical instruments and user-centric wearables, further strengthening Infosys' digital offerings and workforce.
Infosys (NYSE: INFY) has been recognized as a global leader in Digital Process Automation (DPA) Services by Forrester in its Q3 2020 report. The company ranked highest in the 'current offering' category and among the top two in 'strategy.' Highlights include Infosys's strong expertise in large project execution and significant investments in unique intellectual property for DPA platforms. The report emphasizes Infosys's mature customer experience and capabilities in process discovery, modeling, and documentation.
Infosys (NYSE: INFY) announced on October 8, 2020, its agreement to acquire Blue Acorn iCi, a leader in digital customer experience and a significant Adobe partner. This acquisition aims to enhance Infosys' capabilities in digital transformation, particularly in customer experience and commerce analytics. Blue Acorn iCi's expertise across various sectors will complement Infosys' previous acquisition of WONGDOODY, broadening service offerings to clients. The deal is expected to finalize in the third quarter of fiscal 2021, pending customary closing conditions.
Infosys (NYSE: INFY) announced a definitive agreement to acquire Blue Acorn iCi, an Adobe Platinum partner known for its expertise in digital customer experience and commerce. This strategic acquisition aims to enhance Infosys' offerings in digital transformation as it integrates Blue Acorn iCi's capabilities in analytics, design, and engineering. The deal will complement Infosys’ previous acquisition of WONGDOODY and is expected to close in Q3 FY2021, pending customary conditions.
Infosys Public Services has launched the Infosys Health Insights Platform (IHIP), an automated data science solution developed in collaboration with AWS, Couchbase, and Knowi. This platform aims to assist public health agencies in managing and analyzing diverse data sources, including unstructured data, to generate predictive insights and improve decision-making processes, especially relevant during health crises like COVID-19. Leveraging AWS's cloud capabilities, IHIP enhances collaboration among health professionals to better address public health challenges.
Infosys (NYSE: INFY) has been selected by Mobile Health AG to enhance its go-to-market strategy for the ePRO platform, Consilium Care™. This partnership aims to improve cancer patient outcomes through remote monitoring by managing cloud and infrastructure services. Infosys's expertise in oncology and established cloud services were key factors in the selection. The collaboration includes exploring new opportunities to market the platform in the US within the Infosys Health Platform. Both companies aim to optimize treatment quality and patient care through advanced technology.